[1]
“ASSESSMENT OF THE FIRST-TRIMESTER SERUM DOUBLE MARKER TEST CLINICAL EFFECTIVENESS”, Int. Res. J. Pharm., vol. 6, no. 3, pp. 227–230, Mar. 2015, doi: 10.56802/rqj8kq36.